Pancreatic Cancer Research

ResearcherBrunel University of LondonActive in the last 2 years

Uday Kishore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6033-6759; OpenAlex author ID A5062104862. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 9

  1. Rethinking PDAC: from immunological silence to therapeutic opportunity. Co-author DOI 10.3389/fimmu.2026.1909191↗
  2. Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
  3. Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1573522↗
  4. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fimmu.2024.1323198↗
  5. Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreatic cancer Co-author DOI 10.1101/2023.10.28.564512↗
  6. Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. Co-author DOI 10.1172/jci.insight.154475↗
  7. TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer. Co-author DOI 10.1038/s43018-021-00258-w↗
  8. A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines via Fas-Mediated Pathway. Last author DOI 10.3389/fimmu.2018.01126↗
  9. Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β. Last author DOI 10.3389/fimmu.2018.01844↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shiv K. Singh · 7 shared papers, 2018–2025 · strength 1.04
  2. Basel K. al-Ramadi · 3 shared papers, 2024–2026 · strength 0.92
  3. Remya P. G. Ramesh · 2 shared papers, 2025–2026 · strength 0.64
  4. Ann Mary Joseph · 2 shared papers, 2024–2025 · strength 0.58
  5. Lukas Klein · 4 shared papers, 2021–2025 · strength 0.55
  6. Mengyu Tu · 4 shared papers, 2021–2025 · strength 0.55
  7. Volker Ellenrieder · 4 shared papers, 2021–2025 · strength 0.55
  8. Laura Urbach · 3 shared papers, 2021–2025 · strength 0.43
  9. Elisa Espinet Espinet · 3 shared papers, 2021–2025 · strength 0.40
  10. Andreas Trumpp · 3 shared papers, 2021–2025 · strength 0.40
  11. Elisabeth Heßmann · 3 shared papers, 2021–2025 · strength 0.40
  12. Suresh K. Kali · 1 shared paper, 2026 · strength 0.33
  13. Niklas Krebs · 2 shared papers, 2022–2025 · strength 0.30
  14. Argyris Papantonis · 2 shared papers, 2021–2025 · strength 0.28
  15. Albrecht Neeße · 2 shared papers, 2021–2022 · strength 0.22
  16. Anuvinder Kaur · 2 shared papers, 2018 · strength 0.21
  17. Rama Khokha · 1 shared paper, 2025 · strength 0.18
  18. Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
  19. Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.18
  20. Kazeera Aliar · 1 shared paper, 2025 · strength 0.18
  21. Rebecca Diya Samuel · 1 shared paper, 2025 · strength 0.18
  22. Rémy Nicolle · 1 shared paper, 2023 · strength 0.15
  23. Susanne Roth · 1 shared paper, 2023 · strength 0.15
  24. H. Carlo Maurer · 1 shared paper, 2022 · strength 0.12
  25. Silke Cameron · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.